AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
22.87
-0.36 (-1.55%)
At close: Jul 6, 2026, 4:00 PM EDT
22.87
0.00 (0.00%)
After-hours: Jul 6, 2026, 4:22 PM EDT
PSIL Holdings Information
PSIL is an equity ETF with a total of 33 individual holdings. The top holdings are Definium Therapeutics stock at 12.37%, COMPASS Pathways at 11.30%, AtaiBeckley at 10.57%, Relmada Therapeutics at 6.36%, and NRx Pharmaceuticals at 5.88%.
Total Holdings
33
Top 10 Percentage
68.76%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
33.63M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics, Inc. | 12.37% |
| 2 | CMPS | COMPASS Pathways plc | 11.30% |
| 3 | ATAI | AtaiBeckley Inc. | 10.57% |
| 4 | RLMD | Relmada Therapeutics, Inc. | 6.36% |
| 5 | NRXP | NRx Pharmaceuticals, Inc. | 5.88% |
| 6 | NBIX | Neurocrine Biosciences, Inc. | 4.64% |
| 7 | ALKS | Alkermes plc | 4.59% |
| 8 | GHRS | GH Research PLC | 4.44% |
| 9 | ABBV | AbbVie Inc. | 4.41% |
| 10 | NEO: HELP | Cybin Inc. | 4.21% |
| 11 | ANRO | Alto Neuroscience, Inc. | 4.04% |
| 12 | n/a | Blackrock Treasury Trust Instl 62 | 3.90% |
| 13 | JNJ | Johnson & Johnson | 3.83% |
| 14 | CSE: DRUG | Bright Minds Biosciences Inc. | 3.78% |
| 15 | SUPN | Supernus Pharmaceuticals, Inc. | 3.06% |
| 16 | STIM | Neuronetics, Inc. | 2.42% |
| 17 | NEUP | Neuphoria Therapeutics Inc. | 1.97% |
| 18 | CSE: QNTM | Quantum BioPharma Ltd. | 1.89% |
| 19 | OPTI.NE | Optimi Health Corp | 1.38% |
| 20 | KTTA | Pasithea Therapeutics Corp. | 1.19% |
| 21 | SILO | Silo Pharma, Inc. | 1.08% |
| 22 | PBM | Psyence Biomedical Ltd. | 0.86% |
| 23 | IXHL | Incannex Healthcare Inc. | 0.56% |
| 24 | TSX: NUMI | Numinus Wellness Inc. | 0.47% |
| 25 | IGC | IGC Pharma, Inc. | 0.44% |
As of Jul 2, 2026